HOME >> MEDICINE >> NEWS
Results of Yale study confirm aspirin helpful in preventing a first heart attack

New Haven, Conn. An overview by a Yale researcher of four studies examining the use of aspirin and the reduction of heart attacks in persons with no previous history of cardiovascular disease shows aspirin remains a good preventive measure.

The studies included more than 51,000 people and 2,284 "vascular events": vascular disease-related death, cardiac or cerebral; nonfatal heart attack, or nonfatal stroke. The overview article was published in the Archives of Internal Medicine.

"The results reconfirm that aspirin is beneficial in preventing a first myocardial infarction," said Patricia Hebert, associate research scientist in the Department of Medicine, Cardiology, at Yale School of Medicine. "We really did not have enough events to assess the effects of aspirin on overall stroke, ischemic stroke, or cardiovascular death. There was an increase in the risk of hemorrhagic stroke from taking aspirin, which also has been detected in secondary prevention trials."

Individuals that took aspirin had a 32 percent reduction in nonfatal heart attacks. Aspirin did not appear to reduce the number of vascular disease-related deaths, nor lead to any significant decrease in the number of overall or ischemic strokes. There was, however, a slight increase in the risk of hemorrhagic stroke associated with aspirin use.

The overview included four primary prevention trials of aspirin and cardiovascular disease: The Physicians Health Study, The British Doctors Trial, The Thrombosis Prevention Trial, and The Hypertension Optimal Treatment Study.

"In primary prevention, there is conclusive benefit of aspirin in reducing risk of a first myocardial infarction and any important vascular event," Hebert said. "Whether there are any beneficial effects on risks of vascular deaths, overall stroke, or ischemic stroke remains uncertain due to inadequate numbers of events in the primary prevention trials completed to date. While based on small numbers,
'"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
20-Nov-2000


Page: 1 2

Related medicine news :

1. Heart transplant survival: Results may be key to rejection prevention, detection, treatment
2. Docetaxel versus paclitaxel in breast cancer Results of worlds first head to head trial
3. Results from first clinical trial using GVG to treat addiction
4. Results of first chronic treatment study with oral EXANTA(TM) (ximelagatran)
5. Media Advisory-- Results of California autism epidemiology study to be unveiled
6. Results of NUVANCE (IL-4 receptor) in Phase I/II study in asthma patients featured at AAAAI Late-Breaker Abstract and Asthma Therapy Sessions
7. Yale study shows way to re-stimulate brain cell growth: Results could boost understanding of Alzheimers, other brain disorders
8. Results of NUVANCE phase I/II asthma trial presented
9. ILEX Oncology & LeukoSite report results from pivotal Phase II CAMPATH (R) trial; Results suggest new hope for refractory chronic lymphocytic leukemia
10. UI Study Yields Encouraging Results For New Breast Cancer Treatment
11. Ph.D. Degree Research Results In Patent For Low-Cost Pharmaceutical Filters Made From Seafood Waste

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2018)... ... August 14, 2018 , ... Eagle Merchant Partners and ... provider of residential and commercial recreational surfacing products across the country. , The ... used across a wide range of markets and customers. Founded in 1998, Recreational ...
(Date:8/11/2018)... ... August 10, 2018 , ... Dr. Siavash Eftekhari, Oral and Maxillofacial Surgeon ... a week-long international outpost trip to deliver dental care in impoverished communities. Along with ... Dr. Eftekhari volunteered his time to help deliver care to over 550 individuals in ...
(Date:8/11/2018)... ST. PETERSBURG, Fla. (PRWEB) , ... August 10, 2018 , ... ... health and wellness of children in the region by utilizing a population health perspective ... of a population by ensuring families are being treated at the right facility or ...
(Date:8/11/2018)... ... August 11, 2018 , ... Financial ... Award in the Executive of the Year-Business category in The 15th Annual International ... program. All individuals and organizations worldwide – public and private, for-profit and non-profit, ...
(Date:8/9/2018)... ... 2018 , ... Lyme disease is one of the fastest growing epidemics to ... – a 25-fold increase since surveillance began in 1982. According to a new report ... states and the District of Columbia. Yet, Lyme and other insect borne illnesses are ...
Breaking Medicine News(10 mins):
(Date:8/2/2018)... ... August 02, 2018 , ... ... gummy smile for custom crown lengthening treatment at his Eden Prairie, ... line and an unsteady self-conscious. Using decades of experience, Dr. Sanchez is excited ...
(Date:8/2/2018)... ... August 02, 2018 , ... Juan M. Montero, ... international leader of sustainable advocacy. Sharon Kleyne, host of the internationally syndicated radio ... & Your Health sponsored by Nature’s Tears® EyeMist® on VoiceAmerica and World Talk ...
(Date:8/2/2018)... ... August 02, 2018 , ... The Team from Hennessey Performance (HPE) has built ... production of a limited production commemorative vehicle: The 2019 Hennessey Heritage Edition Mustang. ... V8 engine produces 808 horsepower at 7,200 rpm and 677 lb-ft of torque at ...
Breaking Medicine Technology:
Cached News: